May 2008 Volume 5 Number 5
Visit Nature Clinical Practice Oncology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0UgF0EH
=====================================================================
Attending the ASCO Annual Meeting in Chicago this May?
Come and see us at Booth 8120 and pick up your complimentary copy of
Nature Clinical Practice Oncology.
We hope to see you there!
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZx0EV
=====================================================================
----------------------
EDITORIAL
----------------------
More on strong inference
Vincent T DeVita Jr
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZy0EW
----------------------
VIEWPOINT
----------------------
Should adjuvant imatinib be used as primary treatment for
gastrointestinal stromal tumors?
Peter Hohenberger
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZz0EX
----------------------
RESEARCH HIGHLIGHTS
----------------------
A novel combination regimen for the treatment of multiple myeloma
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ10EK
Myelodysplastic syndromes can be effectively treated with lenalidomide
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ20EL
Oral contraceptives confer a lasting reduction in the risk of ovarian
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ30EM
Chemokines mediate preferential metastasis of cutaneous melanoma to the
small intestine
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ40EN
Preoperative serum C-reactive-protein level might predict prognosis in
ovarian cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ50EO
Nomograms for predicting survival of patients with glioblastoma
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ60EP
Sequential versus concomitant chemotherapy and tamoxifen in breast
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ70EQ
Regional lymphadenectomy should be standard for metastasis from melanoma
of unknown primary
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtZ80ER
PFS as a surrogate end point for OS in advanced colorectal cancer trials
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaA0Eh
----------------------
PRACTICE POINTS
----------------------
Which patients with prostate cancer benefit from immediate postoperative
radiotherapy?
Brett Cox and Michael J Zelefsky
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaB0Ei
Is the prevalence of colorectal neoplasm higher in patients with
coronary artery disease?
Alfred I Neugut and Benjamin Lebwohl
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaC0Ej
Metastatic colorectal cancer: irinotecan plus infusional, bolus or oral
fluoropyrimidines as first-line treatment
David J Kerr
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaD0Ek
HER2 positivity predicts a benefit from paclitaxel treatment after
adjuvant chemotherapy
Sudeep Gupta
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaE0El
Does the addition of thalidomide to MP or low-intensity SCT improve
survival in elderly multiple myeloma patients?
Paolo Corradini and Vittorio Montefusco
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaF0Em
----------------------
REVIEWS
----------------------
Transplantation of allogeneic hematopoietic stem cells: an emerging
treatment modality for solid tumors
Taner Demirer, Lisbeth Barkholt, Didier Blaise, Paolo Pedrazzoli,
Massimo Aglietta, Angelo Michele Carella, Jacques-Olivier Bay, Fikret
Arpaci, Giovanni Rosti, Gunhan Gurman, Dietger Niederwieser and Marco
Bregni on behalf of the EBMT Solid Tumors Working Party
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaG0En
Drug Insight: gastrointestinal and hepatic adverse effects of
molecular-targeted agents in cancer therapy
Yohann Loriot, Gabriel Perlemuter, David Malka, Frederique Penault-Lorca,
Valerie Boige, Eric Deutsch, Christophe Massard, Jean Pierre Armand and
Jean-Charles Soria
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaH0Eo
Mechanisms of Disease: epithelial-mesenchymal transition-does cellular
plasticity fuel neoplastic progression?
Eva A Turley, Mandana Veiseh, Derek C Radisky and Mina J Bissell
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaI0Ep
----------------------
CASE STUDY
----------------------
Five donors-one recipient: modeling a mosaic of granulocytes, natural
killer and T cells from cord-blood and third-party donors
Bjorn Schottker, Tobias Feuchtinger, Michael Schumm, Erdwine Klinker,
Rupert Handgretinger, Hermann Einsele and Gernot Stuhler
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaJ0Eq
----------------------
CORRIGENDUM
----------------------
CT screening for lung cancer is justified
Claudia I Henschke
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BtaK0Er
=====================================================================
ESO e-grandround
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BrPN0Eb
The European School of Oncology in partnership with Nature Clinical
Practice Oncology is pleased to announce live e-grandrounds. These
online discussion-based presentations allow participants to submit
questions and take part in lively discussions. We invite you to join
the e-grandrounds, which are broadcast every other Thursday from
17:15-18:00 GMT.
Please visit http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0BrPk0E5
for further information.
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/ekUq0Xztnp0HjM0Zzu0ES
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
